1.
Ganzel C, Kharit M, Duksin C, Rowe JM. Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia. Haematologica [Internet]. 2018Sep.30 [cited 2026Nov.16];103(10):e489-e490. Available from: https://haematologica.org/article/view/8646